| Feb 9, 2021 |
May 27, 2022 |
Elicio Therapeutics, Inc.
|
Officer |
Sell |
17.5
|
-159,177
|
-10.43%
|
✗
|
$2.5M |
| May 25, 2022 |
May 27, 2022 |
Elicio Therapeutics, Inc.
|
Officer |
Buy |
68.8
|
+11,313
|
0.60%
|
✗
|
$14.1K |
| May 20, 2022 |
May 25, 2022 |
Elicio Therapeutics, Inc.
|
Officer |
Buy |
90.0
|
+82,200
|
5.01%
|
✗
|
$101.4K |
| Dec 27, 2021 |
Dec 29, 2021 |
Elicio Therapeutics, Inc.
|
Officer |
Buy |
97.5
|
+277,244
|
20.36%
|
✗
|
$730.4K |
| Dec 20, 2021 |
Dec 22, 2021 |
Elicio Therapeutics, Inc.
|
Officer |
Buy |
60.0
|
+3,527
|
0.26%
|
✗
|
$9K |
| Dec 16, 2021 |
Dec 20, 2021 |
Elicio Therapeutics, Inc.
|
Officer |
Buy |
87.5
|
+41,625
|
3.16%
|
✗
|
$106K |
| Jun 24, 2021 |
Dec 17, 2021 |
Elicio Therapeutics, Inc.
|
Officer |
Sell |
90.0
|
+36,513
|
2.85%
|
✗
|
$379.3K |
| Feb 9, 2021 |
Feb 11, 2021 |
Elicio Therapeutics, Inc.
|
Officer |
Sell |
37.5
|
-191,143
|
-7.85%
|
✗
|
$3.1M |
| Aug 2, 2019 |
Aug 6, 2019 |
EXICURE, INC.
|
Director |
Buy |
97.5
|
+250,000
|
62.49%
|
✗
|
$500K |
| Sep 26, 2017 |
Sep 28, 2017 |
EXICURE, INC.
|
Director |
Buy |
95.0
|
+400,049
|
100.00%
|
✗
|
$200K |
| May 22, 2013 |
Jul 23, 2014 |
IOVANCE BIOTHERAPEUTICS, INC.
|
10% Owner |
Buy |
100.0
|
+5,600,887
|
179056.49%
|
✗
|
$27.4M |
| Jun 28, 2012 |
Jun 29, 2012 |
ABEONA THERAPEUTICS INC.
|
10% Owner |
Sell |
22.5
|
-204,157
|
-7.80%
|
✗
|
$115.9K |
| May 16, 2012 |
May 16, 2012 |
ABEONA THERAPEUTICS INC.
|
10% Owner |
Sell |
22.5
|
-141,300
|
-5.12%
|
✗
|
$94.9K |